top of page

TME 76: Understanding the Impact of Cancer on the Body

Updated: Dec 8, 2025

Cancer takes a heavy toll on the body. It affects the bone marrow, which is the factory that produces:


  • Red blood cells (oxygen carriers)

  • Platelets (clotting/bleeding control)

  • White blood cells (immunity/defense system)


The Damage to Bone Marrow


Two main factors can damage this factory:


  1. Cancer itself (especially leukemia, lymphoma, and marrow-infiltrating cancers)

  2. Chemotherapy, which targets fast-dividing cells—including healthy marrow cells


This leads to:


  • Low hemoglobin

  • Low platelets

  • Low white cell counts


And that is exactly why transfusion support becomes necessary.


Understanding Hemoglobin and Platelet Drops in Cancer Treatment


Chemotherapy drugs are cytotoxic. This means they damage or destroy cells—especially cells that divide rapidly.


The Bone Marrow's Vulnerability


The bone marrow has some of the fastest-dividing cells in the entire body. When chemotherapy hits:


  • Red cells cannot be produced → severe fatigue, breathlessness

  • Platelets drop → bleeding risk

  • WBCs drop → infections skyrocket


This is predictable. It’s not a failure of therapy. It’s a known side effect, and transfusion is the support system that carries patients through treatment.


Essential Blood Components for Cancer Patients


A. Packed Red Blood Cells (PRBCs)


Function: Restore oxygen-carrying capacity so patients can breathe easier and tolerate chemotherapy.


B. Platelets


Function: Prevent or stop bleeding. Cancer patients may need platelets multiple times per week during certain cycles.


C. Fresh Frozen Plasma (FFP)


Function: Replaces clotting factors when the liver is affected or bleeding is present.


D. Cryoprecipitate


Function: Restores fibrinogen in special bleeding disorders or post-chemotherapy conditions.


Not all cancers require all components, but red cells and platelets form the backbone of treatment.


Understanding White Blood Cells (WBCs) and the Importance of Leukoreduction


To understand leukoreduced blood, we need to understand what WBCs do.


What are WBCs?


They are the body’s soldiers. There are different types:


  • Neutrophils → fight bacteria

  • Lymphocytes → coordinate immunity, produce antibodies

  • Monocytes → clean up debris

  • Eosinophils & basophils → respond to allergy/parasitic infections


Each type is part of a highly coordinated defense network.


Challenges with WBCs in Transfusion


When donor WBCs enter another person's body:


  1. They can trigger fevers

  2. They can attack the patient’s tissues

  3. They can carry certain viruses

  4. They increase the risk of forming antibodies

  5. They can cause severe immune reactions in immunocompromised cancer patients


This is where leukoreduction becomes life-saving.


Close-up of a round cell covered in hair-like structures on a dark background. The image is a detailed black and white microscopic view.

Blood Modifications for Cancer Patients


Cancer patients often have weakened immunity and inflamed immune systems. Therefore, we “modify” blood to make it safer. Let’s break down each type simply, with science + how it’s actually done in the blood bank.


A. Leukoreduction: Removing White Blood Cells


What it does: Reduces WBC count in a blood unit by 99.9%.


Why cancer patients need it:


  • Prevents fever after transfusion

  • Reduces infections from donor WBCs

  • Lowers chances of alloimmunization

  • Reduces inflammation

  • Protects immunocompromised patients


How leukoreduction is done: The blood bag is passed through a special micropore filter. This filter traps WBCs but lets red cells or platelets flow through smoothly. There are two methods:


  1. Pre-storage leukoreduction (best) – done inside the blood bank within 24 hours

  2. Bedside leukoreduction – done using inline filters during transfusion


B. Irradiation: Preventing Donor Cells From Attacking the Patient


What it does: Stops donor lymphocytes from multiplying.


Why cancer/bone marrow transplant patients need it: Prevent Transfusion-Associated Graft vs Host Disease (TA-GvHD)—a rare but often deadly reaction where donor WBCs attack the patient.


How irradiation is done: The blood bag is placed inside an irradiator machine (gamma, X-ray, or linear accelerator). The machine exposes the blood to a specific dose—usually 25–50 Gray. This inactivates donor lymphocytes but keeps the blood usable.


C. Apheresis: Collecting Only What the Patient Needs


What it means: Instead of collecting whole blood and separating components later, a donor is connected to an apheresis machine. The machine:


  • Takes blood

  • Separates the needed part (platelets, plasma, granulocytes)

  • Returns the rest back to the donor


Why cancer patients benefit:


  • Fewer donor exposures

  • Higher-quality platelets

  • Custom quantity for each patient

  • Safer for transplant cases


Apheresis platelets are the gold standard for leukemia and post-transplant care.


D. Washed Red Cells / Washed Platelets


What it does: Removes donor plasma proteins that cause allergic reactions.


How washing is done: The blood unit is connected to a centrifuge system that:


  • Spins it

  • Removes plasma

  • Adds saline

  • Repeats the process


This method is used for patients with:


  • Severe allergic reactions

  • IgA deficiency

  • Prior anaphylaxis


Special Requirements for Bone Marrow Transplant (BMT) Patients


Before a transplant, patients undergo conditioning therapy—very high-dose chemotherapy or radiation that wipes out their bone marrow. During this phase, they need:


  • Irradiated PRBCs

  • Irradiated platelets

  • Leukoreduced components

  • Often apheresis platelets

  • Sometimes HLA-matched platelets


After the transplant, they remain dependent on transfusions until the graft starts producing new cells. Blood is not just supportive—it is survival itself during this period.


Surgeons in blue scrubs perform surgery under bright lights. Focused expressions, medical instruments, and a patient under anesthesia are visible.

Can Cancer Patients Receive Normal Blood Without Modification?


They can, but not recommended. Unmodified blood increases risks of:


  • Fever

  • Inflammation

  • Viral transmission

  • Alloimmunization

  • Delayed chemo cycles

  • TA-GvHD

  • Infections


Modified blood is not a luxury—it is the standard of safe care.


The Importance of Understanding Blood Transfusion in Cancer Care


When families understand why transfusions are needed and how blood is made safer, their anxiety drops. A calm mind follows predictable explanations. When fear reduces, treatment acceptance improves. This is psychology, not medicine. Understanding gives strength.


The Hidden Workforce Behind Cancer Care


One cancer patient may require:


  • 10–20 donors per month during chemotherapy

  • Over 40 donors per month if undergoing a transplant


Behind every cancer survivor is an entire unseen team:


  • Voluntary donors

  • Apheresis specialists

  • Transfusion medicine doctors

  • Technicians

  • Counselors

  • Nurses

  • Lab scientists


Cancer care and blood banks are two halves of the same system.


Actionable Takeaways for Patients, Families & Readers


✔ Ask your doctor if you need modified components


Especially irradiated or leukoreduced units.


✔ Inform the blood bank early if a transplant is scheduled


They need preparation time.


✔ Encourage regular voluntary platelet donation


Platelets expire in 5 days—this is a constant need.


✔ Understand that count drops are expected


Don’t panic. They can be managed with timely transfusion.


✔ Share this knowledge


More awareness = more donors = more cancer patients supported.


If this guide helped you understand the science behind blood transfusion in cancer, please:


1. Share this article with caregivers or medical students.


This knowledge empowers people.


2. Encourage someone to donate blood or platelets this month.


One donor can support multiple cancer patients.



This journey of learning and helping others continues here.

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating

thirdthinker

Dr. Arun V. J. is a transfusion medicine specialist and healthcare administrator with an MBA in Hospital Administration from BITS Pilani. He leads the Blood Centre at Malabar Medical College. Passionate about simplifying medicine for the public and helping doctors avoid burnout, he writes at ThirdThinker.com on healthcare, productivity, and the role of technology in medicine.

©2023 by thirdthinker. Proudly created with Wix.com

bottom of page